000 05565naa a22006377i 4500
001 UMUN-OA-20261005-MLS-023
003 local
005 20261005174903.0
006 m o d
007 cr||||||||||||
008 261005s2025 xx o u000 0 eng d
024 7 _a10.1128/cmr.00137-24
_2doi
035 _a(local)EuropePMC:PMC12424361
040 _alocal
_beng
_clocal
041 0 _aeng
100 0 _aDonna M Wolk
_eauthor.
245 1 4 _aThe American Society for Microbiology's evidence-based laboratory medicine practice guidelines for the diagnosis of bloodstream infections using rapid tests: a systematic review and meta-analysis. /
_cDonna M Wolk; J Scott Parrott; N Esther Babady [and others].
264 1 _a[Place of publication not identified] :
_bAmerican Society for Microbiology (ASM),
_c2025.
300 _a1 online resource (1 article).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aPublication type: Review article.
500 _aLinked open-access copy: published version.
506 0 _aOpen access; no subscription required for the linked open-access version.
_fUnrestricted online access
_2star
520 3 _aSUMMARYBloodstream infections (BSIs) are a significant cause of mortality and morbidity. Rapid identification of pathogens and detection of a few resistance markers from positive blood cultures are now possible through the increased availability of commercial rapid diagnostic tests, including nucleic acid amplification tests and matrix-assisted laser desorption ionization time-of-flight mass spectrometry. This document describes the clinical utility of rapid diagnostics performed on positive blood cultures and provides evidence-based laboratory medicine guidelines for using rapid tests to diagnose BSIs in hospitalized adult and pediatric patients. This guideline was developed for use by medical (a.k.a. clinical) microbiologists, medical laboratory professionals, infectious disease clinicians, pharmacists, hospital administrators, healthcare providers, and other stakeholders associated with BSIs. A panel of experts, including medical microbiologists and experts in systematic literature review, was assembled to formulate the Population-Intervention-Comparison-Outcome (PICO) question, review the literature, and provide recommendations for using rapid tests to diagnose BSI and improve patient outcomes. A comprehensive literature search of four electronic bibliographic databases (MEDLINE, Embase, CINAHL, and Cochrane) was conducted to identify studies with measurable outcomes. The panel followed a systematic process, which included a standardized methodology for rating the certainty of the evidence and strength of recommendations using the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) approach. The panel evaluated the literature to answer the question: Does using rapid diagnostic tests improve clinical outcomes in adult and pediatric patients hospitalized with a BSI? Peer-reviewed literature was available to address three outcomes, including time to targeted therapy, mortality, and length of hospital stay. In general, the quality of the evidence was low to moderate due to the paucity of controlled, randomized clinical trial studies. However, eight recommendations were made based on evidence derived from the systematic review of the published literature. To answer the PICO question, the expert committee recommended using rapid diagnostic tests combined with active communication to decrease the time to targeted therapy and length of stay (strong recommendation). While the strength of the evidence for the impact on mortality is low, the panel supports using rapid tests to impact these outcomes. A summary of the recommendations is listed in the Executive Summary, which includes a detailed description of the background, methods, evidence summary, and rationale that supports each recommendation in the full text.
540 _aCreative Commons Attribution. See the linked licence for the applicable terms.
_uhttps://creativecommons.org/licenses/by/4.0/
546 _aIn English.
588 0 _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source.
590 _aCourse allocation: B. Sc. Medical Laboratory Science.
650 4 _aMass spectrometry
650 4 _aBlood culture
650 4 _aGuidelines
650 4 _aDiagnostics
650 4 _aBloodstream Infection
650 4 _aMedical Outcomes
653 _aB. Sc. Medical Laboratory Science
653 _aUMUN open access collection
653 _aclinical chemistry
655 4 _aReview articles.
700 0 _aJ Scott Parrott
_eauthor.
700 0 _aN Esther Babady
_eauthor.
700 0 _aA Brian Mochon
_eauthor.
700 0 _aRyan Tom
_eauthor.
700 0 _aChristen Diel
_eauthor.
700 0 _aJennifer Dien Bard
_eauthor.
700 0 _aAmanda Harrington
_eauthor.
700 0 _aD Jane Hata
_eauthor.
700 0 _aAmity L Roberts
_eauthor.
700 0 _aLindsay Boyce
_eauthor.
700 0 _aJ Kristie Johnson
_eauthor.
773 0 _tClinical microbiology reviews
_gVol. 38, no. 3, (2025), pages/article e0013724
_x0893-8512
856 4 0 _uhttps://europepmc.org/articles/PMC12424361
_yRead open-access publication
_zOpen access.
_70
884 _aCourse selection and automated MARC21 enrichment from Europe PMC metadata.
_g20261005
_khttps://europepmc.org/articles/PMC12424361
_qlocal
942 _n0
999 _c1165
_d1165